Type of Study:
Adults 18 years and older with 2 Diabetes needing insulin
Up to 52 weeks
18 years – 75 years, Male and Female, with a diagnosis of Type 2 Diabetes
Participants will receive at no cost: study product, study materials and study-specific procedures
In this randomized, double-blind, double-dummy, placebo-controlled study, approximately 675 eligible subjects with type 2 diabetes and inadequate control on at least one and up to 3 oral glucose-lowering agents will undergo an initial 21-day Screening Period, followed by a 26-week Double-Blind Treatment Period and a 26-week Double-Blind Treatment Extension Period.